Atlas Trials

Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease

Clinical trial NCT04206007 · UNKNOWN

Trial details

NCT number
NCT04206007
Sponsor
Meridigen Biotech Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease Moderate
Start date
2020-06-11
Primary completion
2023-12-31
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.